Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1142166
Disease: Brugada Syndrome (disorder)
Brugada Syndrome (disorder)
0.620 GeneticVariation disease BEFREE CACNA1C, CACNB2b, and CACNA2D1 genes of 162 probands with BrS and BrS+SQT, 19 with IVF, and 24 with ERS were screened by direct sequencing. 20817017 2010
CUI: C0030193
Disease: Pain
Pain
0.310 AlteredExpression phenotype BEFREE Here, we show that Cacna2d1 overexpression potentiates presynaptic and postsynaptic NMDAR activity of spinal dorsal horn neurons to cause pain hypersensitivity. 29490268 2018
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.030 Biomarker disease BEFREE We examined the genetic variants of THBS1 and CACNA2D1 in two independent cohorts of patients affected by IGE/GGE recruited through the Genetic Commission of the Italian League Against Epilepsy (LICE) and the EuroEPINOMICS-CoGIE Consortium. 28913875 2017
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.030 GeneticVariation disease BEFREE Five patients with RE carried a rare CNV that disrupted genes associated with other epilepsies (<i>KCTD7</i>, <i>ARHGEF15</i>, <i>CACNA2D1, GRIN2A</i> and <i>ARHGEF4</i>), and 17 cases carried CNVs that disrupted genes associated with other neurological conditions or that are involved in neuronal signalling/development. 29789371 2018
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.030 GeneticVariation disease BEFREE Genomic aberrations of the CACNA2D1 gene in three patients with epilepsy and intellectual disability. 25074461 2015
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 Biomarker group BEFREE Our previous studies have confirmed that α2δ1 has the potential to function as a cancer stem cell marker, and CACNA2D1 is the coding gene of α2δ1. 31725046 2020
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.020 Biomarker group BEFREE Calcium channel α2δ1 subunit (CACNA2D1) enhances radioresistance in cancer stem-like cells in non-small cell lung cancer cell lines. 30464601 2018
Malignant hyperpyrexia due to anesthesia
0.020 GeneticVariation disease BEFREE The proximity to the WS region of the gene encoding the L-type voltage-gated calcium channel alpha 2/delta-subunit (CACNL2A) on 7q11.23-q21.1, previously shown to be closely linked to some forms of MH susceptibility, prompted us to investigate whether this gene is deleted in WS. 8707301 1996
Malignant hyperpyrexia due to anesthesia
0.020 Biomarker disease BEFREE CACNA2 encodes the alpha(2)/delta subunit of the human voltage-gated calcium channels and is located in the candidate region of malignant hyperthermia susceptibility type 3 (MHS3). 10534405 1999
CUI: C0595921
Disease: Intraocular pressure disorder
Intraocular pressure disorder
0.020 Biomarker disease BEFREE Previously, we identified the calcium voltage-gated channel auxiliary subunit alpha2delta 1 gene (<i>Cacna2d1</i>) as a modulator of IOP and demonstrated that pregabalin, a drug with high affinity and selectivity for CACNA2D1, lowered IOP in a dose-dependent manner. 31714057 2019
CUI: C0595921
Disease: Intraocular pressure disorder
Intraocular pressure disorder
0.020 Biomarker disease BEFREE Because our study utilizes a genetically diverse population of mice with known sequence variants, we are able to determine that the intraocular pressure-lowering effect of pregabalin is dependent on the Cacna2d1 haplotype. 29176626 2017
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 Biomarker group BEFREE Calcium channel α2δ1 subunit (CACNA2D1) enhances radioresistance in cancer stem-like cells in non-small cell lung cancer cell lines. 30464601 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.020 Biomarker group BEFREE Our previous studies have confirmed that α2δ1 has the potential to function as a cancer stem cell marker, and CACNA2D1 is the coding gene of α2δ1. 31725046 2020
CUI: C0004509
Disease: Azoospermia
Azoospermia
0.010 Biomarker disease BEFREE This is the first report describing chromosome insertion inv ins (18,7) and attributes DPP6 and CACNA2D1 to azoospermia. 24937803 2014
CUI: C0017601
Disease: Glaucoma
Glaucoma
0.010 Biomarker disease BEFREE Systems genetics identifies a role for Cacna2d1 regulation in elevated intraocular pressure and glaucoma susceptibility. 29176626 2017
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.010 PosttranslationalModification disease BEFREE CACNA2D1/3 methylation was detected in 10 (12.5%) and 24 (30%) of the 80 GC cases, respectively, but no CACNA2D2 methylation was seen in 32 cases. 18588891 2008
CUI: C0037769
Disease: West Syndrome
West Syndrome
0.010 Biomarker disease BEFREE We provide additional evidence for NR2F1 as a causative gene and for CACNA2D1 and BRWD3 as candidate genes for West syndrome. 25877686 2015
CUI: C0175702
Disease: Williams Syndrome
Williams Syndrome
0.010 GeneticVariation disease BEFREE Linkage studies and fluorescence in situ hybridization analysis demonstrated that the CACNL2A locus is localized outside the WS deleted region. 8707301 1996
CUI: C0339573
Disease: Glaucoma, Primary Open Angle
Glaucoma, Primary Open Angle
0.010 GeneticVariation disease BEFREE Using human genome-wide association study (GWAS) data, evidence for association of a CACNA2D1 single-nucleotide polymorphism and primary open angle glaucoma is found. 29176626 2017
CUI: C0424295
Disease: Hyperactive behavior
Hyperactive behavior
0.010 Biomarker phenotype BEFREE Inhibiting α2δ-1 with gabapentin, uncoupling the α2δ-1-NMDAR interaction with an α2δ-1 C terminus-interfering peptide, or genetically ablating Cacna2d1 had no effect on basal NMDAR currents but strikingly abolished oxygen-glucose deprivation-induced NMDAR hyperactivity in hippocampal CA1 neurons. 30355118 2018
CUI: C1720983
Disease: Channelopathies
Channelopathies
0.010 GeneticVariation disease BEFREE The sequence analysis provides the basis for comprehensive mutation screening of CACNA2 for putative MHS3 individuals and patients with other channelopathies. 10534405 1999
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.010 AlteredExpression disease BEFREE In addition, the expression of CACNA2D1 and PBX3 mRNA is predictive of poor prognosis for HCC patients. 26420065 2015
CUI: C2348199
Disease: Short Qt Syndrome
Short Qt Syndrome
0.010 GeneticVariation disease BEFREE In the present study, we report the first pathogenic mutation in the CACNA2D1 gene in humans, which causes a new variant of SQTS. 21383000 2011
Ventricular Fibrillation, Paroxysmal Familial, 1
0.010 GeneticVariation disease BEFREE The inherited-familial forms are not frequent in IVF; however mutations were identified in the genes KCNJ8, DPP6, SCN5A, SCN3B, CACNA1C, CACNB2, and CACNA2D1. 22825893 2012
Amelogenesis imperfecta nephrocalcinosis
0.010 Biomarker disease BEFREE These results are the first to identify CACNA2D1 as a novel BrS susceptibility gene and CACNA1C, CACNB2, and CACNA2D1 as possible novel ERS susceptibility genes. 20817017 2010